Menu Search
Equities

Novozymes A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NVZMF:PKL

Novozymes A/S

Actions
  • Price (USD)65.84
  • Today's Change0.00 / 0.00%
  • Shares traded439.00
  • 1 Year change+1.51%
  • Beta0.5727
Data delayed at least 15 minutes, as of Sep 14 2026 20:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Jul-26
  • 20-Aug-26
  • 10-Sep-26
Select bar for recommendation details.
Recommendations10-Sep-26
Buy0
Outperform0
Hold0
Sell1
Strong Sell0

Share price forecast in EUR

The one analyst offering a 12 month price target expects Novozymes A/S share price to rise to 165.00 in the next year from the last price of 65.84.
High150.6%165.00
Med150.6%165.00
Low150.6%165.00

Dividends in EUR

Historical dividend information is not available for Novozymes A/S.
Note: The percentage change is calculated using unrounded (raw) dividend values.
Div growth (TTM)4.67%
More ▼

Earnings history & estimates in EUR

On Aug 19, 2026, Novozymes A/S reported 2nd quarter 2026 earnings of 0.52 per share. This result exceeded the 0.40 expectation of the one analyst covering the company and exceeded last year's 2nd quarter results by 10.64%.
The next earnings announcement is expected on Nov 06, 2026.
Average growth rate+3.55%
Novozymes A/S reported annual 2025 earnings of 1.49 per share on Feb 25, 2026.
Average growth rate+1.09%
More ▼

Revenue history & estimates in EUR

-32768 had 2nd quarter 2026 revenues of 1.12bn. This bettered the 1.10bn consensus of the 4 analysts covering the company. This was 3.58% above the prior year's 2nd quarter results.
Average growth rate+2.54%
-32768 had revenues for the full year 2025 of 4.16bn. This was 5.38% above the prior year's results.
Average growth rate+22.19%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.